FDA Adverse Event Injury Summary report: N

SPYSCOPE DS II ACCESS & DELIVERY CATHETER

MDR report key: 17170085 · Received June 21, 2023

Report

Report Number
3005099803-2023-03269
Event Type
Injury
Date Received
June 21, 2023
Date of Event
May 1, 2023
Report Date
June 21, 2023
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
FBN
PMA / PMN Number
K183636
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

BLOCK B3 (DATE OF EVENT): DATE OF EVENT WAS APPROXIMATED TO (B)(6) 2023 AS NO EVENT DATE WAS REPORTED. BLOCK D4, H4: THE COMPLAINANT WAS UNABLE TO REPORT THE LOT NUMBER; THEREFORE THE MANUFACTURE DATE AND EXPIRATION DATE ARE UNKNOWN. BLOCK H6 (PATIENT CODES): IMDRF PATIENT CODE (B)(6) CAPTURES THE REPORTABLE EVENT OF PANCREATITIS. IMDRF PATIENT CODE (B)(6) CAPTURES THE REPORTABLE EVENT OF CHOLANGITIS. IMDRF PATIENT CODE (B)(6) CAPTURES THE REPORTABLE EVENT OF PERFORATION. IMDRF PATIENT CODE (B)(6) CAPTURES THE REPORTABLE EVENT OF HEMORRHAGE. IMDRF IMPACT CODE (B)(6) CAPTURES THE REPORTABLE EVENT OF SERIOUS INJURY.

Description of Event or Problem · 0

IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AT THE 105TH ANNUAL MEETING OF THE JAPANESE SOCIETY FOR GASTROINTESTINAL ENDOSCOPY (JGES) A RETROSPECTIVE REVIEW OF 35 CASES AND 47 PROCEDURES (26 MALES AND 9 FEMALES, MEDIAN AGE 68 (22-86) YEARS) USING ORAL PANCREATOSCOPE (POPS) FROM (B)(6) 2017 TO (B)(6) 2022 WAS PERFORMED TO DETERMINE PANCREATIC STONE TREATMENT OUTCOMES AND ASSOCIATED FACTORS. THE SPYSCOPE DS II WAS USED FOR THESE PROCEDURES. THE REVIEW FOUND EIGHT CASES OF PANCREATITIS, TWO CASES OF CHOLANGITIS, ONE CASE OF PERFORATION, AND ONE CASE OF HEMORRHAGE. TWELVE CASES WERE FOUND TO HAVE AN INCIDENTAL COMPLICATION AND ONE CASE RESULTED IN EMERGENCY SURGERY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
252109 SPYSCOPE DS II ACCESS & DELIVERY CATHETER CHOLEDOCHOSCOPE AND ACCESSORIES, FLEXIBLE/RIGID FBN BOSTON SCIENTIFIC CORPORATION M00546610

Patients

Seq Age Sex Outcome Treatment
1 Unknown Required Intervention